Ochronosis
Ochronosis is a serious metabolic skin disorder in which alkapton pigments (derived from homogentisic acid, HGA) are deposited as microscopic yellow-brown, ochre-colored particles within the collagen and elastic fiber network of the dermis. Clinically, it appears as patches, papules or a net-like pattern of blue-black, blue-gray or dark gray-brown pigment, concentrated on sun-exposed skin or over cartilage.
Ochronosis has two forms with entirely different causes. Endogenous ochronosis (alkaptonuria) is an inherited recessive disorder of the gene encoding homogentisate 1,2-dioxygenase. Exogenous ochronosis (EO) results from overuse of topical tyrosinase inhibitors, especially high-strength hydroquinone over long periods. At Haute-Derma, recognizing exogenous ochronosis early is essential: it means stopping the offending cream immediately, avoiding a mistaken diagnosis of ordinary melasma, and using a 1064 nm picosecond laser to remove dermal pigment safely.
Pathogenesis and How Pigment Builds Up in the Dermis
Ochronosis develops as homogentisic acid derivatives form and polymerize in the dermis:
- Endogenous form (alkaptonuria): an autosomal recessive mutation in the HGD gene leaves the body completely without the enzyme homogentisate 1,2-dioxygenase. This blocks the breakdown of the amino acids phenylalanine and tyrosine, so homogentisic acid (HGA) builds up to very high levels in the blood and is excreted in the urine (which turns black on standing in air). HGA in the blood binds to collagen in cartilage (ears, joints) and skin, where it oxidizes into an insoluble pigmented polymer.
- Exogenous form (EO): caused by prolonged topical hydroquinone (HQ) use (strengths above 2–4% for months or years). HQ penetrates deep into the dermis and locally inhibits the enzyme homogentisate oxidase. With HGA metabolism disrupted in the skin, HGA accumulates, oxidizes and polymerizes into ochronotic pigment that clings tightly to dermal collagen fibers.
- Histopathology: ochronotic pigment attaches to collagen fibers, which degenerate, swell, fragment and become distorted into pale yellow-brown "banana-shaped bodies" on H&E staining. Over time, the dermis responds with elastic fiber degeneration and a foreign body inflammatory reaction.
Differential Diagnosis: Endogenous Ochronosis, Exogenous Ochronosis and Melasma
| Endogenous Ochronosis (Alkaptonuria) | Exogenous Ochronosis (EO) | Melasma |
|---|---|---|
| Inherited HGD gene mutation (body-wide HGD enzyme deficiency) | Local toxicity from overuse of hydroquinone, phenol, resorcinol | Hormonal changes, UV light and chronic inflammation stimulating melanocytes |
| Unrelated to topical products | History of long-term high-strength hydroquinone use (> 3–6 months) | May or may not have used HQ; no toxic pigment reaction |
| Black urine, blue-black ear cartilage, stiff joints, calcified spinal discs | Changes limited to the skin where the product was applied | No cartilage or internal organ involvement at all |
| Symmetric pigmentation of the ears, whites of the eyes and palms | Tiny caviar-like papules; blue-black or gray-brown patches around the cheekbones | Light to dark brown patches with blurred edges, not raised |
| Brown-blue spotty pigment in cartilage and sclera | Gray-blue ring/disc or droplet structures around hair follicle openings | Brown epidermal pigment network, no gray discs |
Examination, Dermoscopy and Dogliotti Staging at Haute-Derma
- Medication and Clinical History
- A detailed history of every whitening product, home-mixed cream and melasma treatment used (especially those containing hydroquinone or high-dose arbutin).
- Checking the cartilage and urine to rule out endogenous alkaptonuria.
- Detailed Dermoscopy
- Typical dermoscopic features of EO: loss of the normal pigment network, with tiny gray-blue or brown-black disc-like structures or caviar-like granules surrounding the follicular openings.
- Dogliotti Clinical Staging
- Stage 1 (mild): mild redness and streaky hyperpigmentation on the cheeks/temples.
- Stage 2 (moderate): tiny blue-black caviar-like papules and rough skin.
- Stage 3 (severe): nodular lesions and widespread hard blue-black plaques, with loss of skin elasticity.
Treatment Protocol at Haute-Derma
Exogenous ochronosis is one of the toughest problems in aesthetic dermatology. Our protocol requires patience and strict adherence:
- STOP Hydroquinone and Other Offending Agents Immediately: hydroquinone, arbutin, phenol and any whitening creams of unknown origin are removed completely from the patient's skin care routine.
- Removing Dermal Pigment with a 1064 nm Picosecond Laser
- How it works: a 1064 nm wavelength with picosecond pulses delivers photomechanical energy that shatters the ochronotic polymer deposits in the dermis into tiny particles that macrophages can clear.
- Settings: moderate fluence (1.0–1.5 J/cm²) and a 4–6 mm spot size, applied gently to avoid triggering post-inflammatory hyperpigmentation (PIH) in already damaged skin.
- Course: 8–12 sessions, spaced 4–6 weeks apart.
- Rebuilding the Dermis with Fractional CO2 / Erbium:YAG Laser: fractional resurfacing is added to remove collagen fibers damaged by ochronotic pigment and to stimulate a new, healthy collagen and elastin network.
- Barrier-Repairing Cosmeceuticals and Broad-Spectrum Sun Protection
- Soothing, anti-inflammatory and strongly antioxidant topicals: 5% niacinamide, vitamin C (L-ascorbic acid), ferulic acid, ceramides and panthenol.
- A mineral sunscreen with zinc oxide and titanium dioxide plus iron oxides is mandatory to block both UV and visible light.
